Coming Soon

Public Funding for Vidiia Ltd

Registration Number 12682252

New smart diagnostics for infection

9,085
2019-01-01 to 2022-07-31
Collaborative R&D
Currently, diagnosing a bacterial infection and selecting the correct antibiotic treatment can take up to 48hrs and this often results in clinicians prescribing broad spectrum antibiotics, which may result in the development of antibiotic resistance. This project aims to develop rapid, accurate and economical diagnostic tests for use in China that will provide a diagnosis in less than 30 minutes without the need for complex laboratory equipment. Furthermore, the tests will provide important information on antibiotic resistance, therefore enabling the clinician to prescribe the most effective treatment and avoid the development of antibiotic resistance. The project also aims to develop a Therapeutic Drug Monitoring (TDM) system that antibiotic treatments can be accurately monitored through a simple blood test. The TDM will ensure that patients receive the correct dosages of antibiotics for a given infection, thus ensuring rapid treatment of the infection and avoidance of antibiotic resistance. The project will also develop a knowledge-based platform will help physicians track infectious disease in China and provide advice to physicians on appropriate control strategies.

Get notified when we’re launching.

Want fast, powerful sales prospecting for UK companies? Signup below to find out when we're live.